GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Clal Biotechnology Industries Ltd (XTAE:CBI) » Definitions » E10

Clal Biotechnology Industries (XTAE:CBI) E10 : ₪0.00 (As of Dec. 2023)


View and export this data going back to 2007. Start your Free Trial

What is Clal Biotechnology Industries E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Clal Biotechnology Industries's adjusted earnings per share data for the three months ended in Dec. 2023 was ₪0.000. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is ₪0.00 for the trailing ten years ended in Dec. 2023.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2024-06-10), Clal Biotechnology Industries's current stock price is ₪0.417. Clal Biotechnology Industries's E10 for the quarter that ended in Dec. 2023 was ₪0.00. Clal Biotechnology Industries's Shiller PE Ratio of today is .

During the past 13 years, the highest Shiller PE Ratio of Clal Biotechnology Industries was 177.29. The lowest was 0.00. And the median was 150.43.


Clal Biotechnology Industries E10 Historical Data

The historical data trend for Clal Biotechnology Industries's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Clal Biotechnology Industries E10 Chart

Clal Biotechnology Industries Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - -0.79 -1.02 -1.02 -

Clal Biotechnology Industries Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Jun23 Dec23
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.05 -1.03 -1.02 - -

Competitive Comparison of Clal Biotechnology Industries's E10

For the Biotechnology subindustry, Clal Biotechnology Industries's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Clal Biotechnology Industries's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Clal Biotechnology Industries's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Clal Biotechnology Industries's Shiller PE Ratio falls into.



Clal Biotechnology Industries E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Clal Biotechnology Industries's adjusted earnings per share data for the three months ended in Dec. 2023 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2023 (Change)*Current CPI (Dec. 2023)
=0/129.4194*129.4194
=0.000

Current CPI (Dec. 2023) = 129.4194.

Clal Biotechnology Industries Quarterly Data

per share eps CPI Adj_EPS
201309 -0.320 98.790 -0.419
201312 -0.460 98.326 -0.605
201403 -0.390 99.695 -0.506
201406 3.270 100.560 4.208
201409 -3.590 100.428 -4.626
201412 -2.120 99.070 -2.769
201503 -0.210 99.621 -0.273
201506 -0.090 100.684 -0.116
201509 -0.230 100.392 -0.297
201512 -0.340 99.792 -0.441
201603 -0.170 100.470 -0.219
201606 -0.270 101.688 -0.344
201609 -0.310 101.861 -0.394
201612 -0.820 101.863 -1.042
201703 -0.130 102.862 -0.164
201706 -0.030 103.349 -0.038
201709 0.080 104.136 0.099
201712 -0.120 104.011 -0.149
201803 -0.170 105.290 -0.209
201806 -0.190 106.317 -0.231
201809 0.030 106.507 0.036
201812 0.040 105.998 0.049
201903 -0.080 107.251 -0.097
201906 -0.490 108.070 -0.587
201909 -0.170 108.329 -0.203
201912 -0.220 108.420 -0.263
202003 -0.020 108.902 -0.024
202006 0.090 108.767 0.107
202009 -0.110 109.815 -0.130
202012 0.720 109.897 0.848
202103 -0.020 111.754 -0.023
202106 -0.220 114.631 -0.248
202109 -0.120 115.734 -0.134
202112 -0.210 117.630 -0.231
202203 0.010 121.301 0.011
202206 -0.220 125.017 -0.228
202209 -0.140 125.227 -0.145
202212 -0.040 125.222 -0.041
202306 0.000 128.729 0.000
202312 0.000 129.419 0.000

Add all the adjusted EPS together and divide 10 will get our e10.


Clal Biotechnology Industries  (XTAE:CBI) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

During the past 13 years, the highest Shiller P/E Ratio of Clal Biotechnology Industries was 177.29. The lowest was 0.00. And the median was 150.43.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Clal Biotechnology Industries E10 Related Terms

Thank you for viewing the detailed overview of Clal Biotechnology Industries's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


Clal Biotechnology Industries (XTAE:CBI) Business Description

Traded in Other Exchanges
N/A
Address
Azrieli Center, Triangle Building, 45th Floor, Tel Aviv, ISR, 67023
Clal Biotechnology Industries Ltd is a life sciences investment company. The company invests in companies ranging from seed to maturity, both public and private. Its portfolio of investments includes from heavy industry to biotechnology, hi-tech and energy companies.

Clal Biotechnology Industries (XTAE:CBI) Headlines

From GuruFocus

Does the Increase in Volatility Signal a Dangerous Market Environment?

By Chuck Carnevale Chuck Carnevale 11-11-2016

Van Den Berg Almost Sells Out 4 Stakes in 1st Quarter

By David Goodloe David Goodloe 04-20-2016

CB&I Announces Novolen Technology Award in China

By PRNewswire PRNewswire 04-03-2018

CBI: Former Buffett Stock Worth Buying Now

By Jonathan Poland Jonathan Poland 06-29-2017

Arnold Van Den Berg Keeps Buying Chicago Bridge and Iron Company

By Ashish Sharma Lalitsharma 05-26-2015

McDermott Announces Ethylene Furnace Award in Indonesia

By PRNewswire PRNewswire 01-24-2019

CB&I Announces Preliminary First Quarter 2018 Financial Results

By PRNewswire PRNewswire 04-12-2018